Table 2.
Type of ED visit | Proportions | ORs | AORsa | AORs (male)b | AORs (female)b | |
---|---|---|---|---|---|---|
| ||||||
BZD Rx | No BZD Rx | |||||
Overdose | 0.03 | 0.03 | 1.34 [0.27–6.63] | 1.19 [0.23–6.22] | – [– –]c | 1.80 [0.29–11.34] |
Accidental injury | 0.26 | 0.09 | 3.75 [1.81–7.75]** | 3.20 [1.50–6.83]** | 1.67 [0.43–6.48] | 4.72 [1.75–12.70]** |
Psychiatric visit | 0.21 | 0.12 | 1.94 [0.93–4.05] | 1.86 [0.87–3.99] | 0.79 [0.17–3.63] | 2.91 [1.11–7.63]* |
Medical visit (e.g. infection) | 0.38 | 0.29 | 2.09 [1.15–3.82]* | 1.93 [1.03–3.60]* | 1.21 [0.43–3.36] | 2.65 [1.17–6.01]* |
Benzodiazepine prescription = BZD Rx.
Adjusted odds ratios (AORs): adjusted for total weeks in program, gender, and BZD misuse.
Gender-AORs demonstrate gender/BZD Rx interaction effect.
No overdose-related visits occurred among males with BZD Rx.
p < 0.05.
p < 0.01.